Expand with integrity

Integration Communications was founded in 2020 by Brad Burge, with over 15 years experience building global audiences in the fields of psychedelic therapy, psychedelic science, health education, health policy, drug policy reform, medical cannabis, and clinical trials. Previously, Brad served as Director of Strategic Communications for the Multidisciplinary Association for Psychedelic Studies (MAPS), where he played a key role in shaping new cultural narratives around psychedelics as legitimate tools. 

The current revolution in wellness and mental health is positioning psychedelics to be the first new approach to Western healthcare in decades. They’re bringing with them an entire new psychedelic industry. Integration Communications helps new and established companies communicate about psychedelics to your target audiences in a way that reduces stigma, enhances trust, and remains in alignment with ethical values.

In the psychedelic industry, reputation is earned, not purchased. With decades of stigma behind them, psychedelics like psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and others are poised for a breakthrough. For new companies entering the  psychedelic space, and for established brands wanting to keep up with shifts in public culture and mental health care, the challenge is to establish trust with donors, investors, and consumers; and to remain accessible to those who are skeptical.